查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings Inc. Common Stock | 4.52 2026-12-31 | 3.38 – 5.35 | 4 | +0.59% | +2.99% | +1.07% | 0 / 2 | $1.02B |
| BVS Bioventus Inc. Class A Common Stock | 0.78 2026-12-31 | 0.77 – 0.79 | 5 | +0.52% | +0.52% | +3.08% | 3 / 0 | $605.76M |
| BIO Bio-Rad Laboratories Inc. Class A Common Stock | 9 2026-12-31 | 8.55 – 9.72 | 5 | 0.00% | 0.00% | -2.29% | 0 / 4 | $2.57B |
| PCRX Pacira BioSciences Inc. Common Stock | 2.88 2026-12-31 | 2.74 – 2.98 | 6 | 0.00% | 0.00% | +9.30% | 6 / 1 | $767.79M |
| TECH Bio-Techne Corp Common Stock | 1.92 2026-06-30 | 1.86 – 1.94 | 13 | -0.04% | -0.04% | -2.94% | 0 / 1 | $1.21B |
| BMRN BioMarin Pharmaceutical Inc. Common Stock | 4.93 2026-12-31 | 4.86 – 5.03 | 17 | -0.10% | -0.05% | -7.84% | 1 / 0 | $3.87B |
| ZBH Zimmer Biomet Holdings Inc. Common Stock | 8.47 2026-12-31 | 8.29 – 8.53 | 27 | -0.08% | -0.07% | +0.00% | 6 / 1 | $8.55B |
| KRYS Krystal Biotech Inc. Common Stock | 8.21 2026-12-31 | 6.21 – 14.52 | 9 | 0.00% | -1.03% | +8.35% | 0 / 1 | $516.05M |
| ADMA ADMA Biologics Inc Common Stock | 0.8 2026-12-31 | 0.78 – 0.83 | 3 | -2.05% | -2.05% | -13.87% | 0 / 1 | $534.33M |
| NBIX Neurocrine Biosciences Inc. Common Stock | 9.93 2026-12-31 | 6.2 – 18.18 | 16 | -0.19% | -2.46% | +3.10% | 1 / 0 | $3.79B |
| BIIB Biogen Inc. Common Stock | 12.46 2026-12-31 | 11.88 – 13.47 | 23 | +3.58% | -6.51% | -7.42% | 1 / 1 | $10.38B |
| ABCL AbCellera Biologics Inc. Common Shares | -0.65 2026-12-31 | -0.71 – -0.59 | 6 | — | — | — | 4 / 0 | $31.98M |
| ACET Adicet Bio Inc. Common Stock | -8.8 2026-12-31 | -12.19 – -5.28 | 5 | — | — | — | 1 / 0 | $0 |
| ADPT Adaptive Biotechnologies Corporation Common Stock | -0.54 2026-12-31 | -0.56 – -0.53 | 4 | — | — | — | 5 / 1 | $293.78M |
| ALMR Alamar Biosciences Inc. Common Stock | -1.46 2026-12-31 | -1.65 – -1.24 | 4 | — | — | — | 0 / 0 | $113.22M |
| ANAB AnaptysBio Inc. Common Stock | -0.23 2026-12-31 | -2.63 – 2.49 | 5 | — | — | — | 0 / 4 | $94.28M |
| ARQT Arcutis Biotherapeutics Inc. Common Stock | 0.18 2026-12-31 | -0.05 – 0.33 | 6 | — | — | -38.47% | 1 / 2 | $500.09M |
| ARTV Artiva Biotherapeutics Inc. Common Stock | -2.43 2026-12-31 | -2.67 – -2.18 | 4 | — | — | — | 1 / 0 | $0 |
| AURA Aura Biosciences Inc. Common Stock | -1.6 2026-12-31 | -2 – -1.41 | 4 | — | — | — | 2 / 1 | $0 |
| AVBP ArriVent BioPharma Inc. Common Stock | -4.09 2026-12-31 | -4.62 – -3.62 | 11 | — | — | — | 0 / 2 | $0 |
| BBIO BridgeBio Pharma Inc. Common Stock | -2.14 2026-12-31 | -2.58 – -1.5 | 8 | — | — | — | 3 / 1 | $961.16M |
| BBOT BridgeBio Oncology Therapeutics Inc. Common Stock | -2.21 2026-12-31 | -2.72 – -1.72 | 10 | — | — | — | 0 / 1 | $0 |
| BDSX Biodesix Inc. Common Stock | -2.96 2026-12-31 | -3.06 – -2.86 | 7 | — | — | — | 1 / 0 | $111M |
| BHST BioHarvest Sciences Inc. Common Stock | -0.41 2026-12-31 | -0.46 – -0.35 | 4 | — | — | — | 0 / 3 | $42.89M |
| BHVN Biohaven Ltd. Common Shares | -2.41 2026-12-31 | -3.05 – -1.83 | 8 | — | — | — | 3 / 3 | $0 |
| BIOA BioAge Labs Inc. Common Stock | -2.48 2026-12-31 | -3.03 – -2.12 | 7 | — | — | — | 3 / 1 | $54.29M |
| BLTE Belite Bio Inc American Depositary Shares | -3.3 2026-12-31 | -4.28 – -2.77 | 7 | — | — | — | 2 / 5 | $0 |
| BMEA Biomea Fusion Inc. Common Stock | -1.08 2026-12-31 | -1.37 – -0.71 | 5 | — | — | — | 2 / 0 | $0 |
| BNTC Benitec Biopharma Inc. Common Stock | -1 2026-06-30 | -1.07 – -0.96 | 6 | — | — | — | 4 / 0 | $0 |
| BNTX BioNTech SE American Depositary Share | -4.28 2026-12-31 | -5.85 – -3.3 | 8 | — | — | — | 3 / 2 | $2.17B |
| BOLT Bolt Biotherapeutics Inc. Common Stock | -238.28 2026-12-31 | -686 – -11.1 | 3 | — | — | — | 0 / 0 | $1.51M |
| CABA Cabaletta Bio Inc. Common Stock | -1.34 2026-12-31 | -1.64 – -1 | 5 | — | — | — | 1 / 0 | $0 |
| CBIO Crescent Biopharma Inc. Common Stock | -2.49 2026-12-31 | -2.73 – -2.22 | 3 | — | — | — | 0 / 1 | $2.08M |
| CLRB Cellectar Biosciences Inc. Common Stock | -2.17 2026-12-31 | -2.85 – -1.47 | 4 | — | — | — | 1 / 0 | $0 |
| CLYM Climb Bio Inc. Common Stock | -0.87 2026-12-31 | -0.98 – -0.7 | 8 | — | — | — | 5 / 0 | $0 |
| CNTB Connect Biopharma Holdings Limited Ordinary Shares | -1.05 2026-12-31 | -1.14 – -0.8 | 5 | — | — | — | 4 / 0 | $41.83M |
| COGT Cogent Biosciences Inc. Common Stock | -2.26 2026-12-31 | -2.7 – -1.96 | 10 | — | — | — | 2 / 7 | $9.9M |
| CRBU Caribou Biosciences Inc. Common Stock | -1.25 2026-12-31 | -1.36 – -1.15 | 3 | — | — | — | 0 / 1 | $25.66M |
| CSTL Castle Biosciences Inc. Common Stock | -1.42 2026-12-31 | -1.77 – -0.84 | 9 | — | — | — | 3 / 5 | $352.29M |
| DARE Dare Bioscience Inc. Common Stock | -0.95 2026-12-31 | -1.37 – -0.57 | 3 | — | — | — | 2 / 0 | $2.11M |
| DTIL Precision BioSciences Inc. Common Stock | -2.49 2026-12-31 | -3.12 – -1.7 | 3 | — | — | — | 1 / 0 | $18.81M |
| FBRX Forte Biosciences Inc. Common Stock | -3.83 2026-12-31 | -4.48 – -3.22 | 5 | — | — | — | 4 / 1 | $0 |
| GENB Generate Biomedicines Inc. Common Stock | -2.24 2026-12-31 | -2.4 – -2.11 | 4 | — | — | — | 0 / 3 | $25.89M |
| GOSS Gossamer Bio Inc. Common Stock | -0.37 2026-12-31 | -0.55 – -0.23 | 7 | — | — | — | 1 / 0 | $28.86M |
| IBIO iBio Inc. Common Stock | -0.33 2026-06-30 | -0.47 – -0.25 | 7 | — | — | — | 2 / 0 | $142.86K |
| IBRX ImmunityBio Inc. Common Stock | -0.84 2026-12-31 | -0.88 – -0.8 | 4 | — | — | — | 0 / 1 | $222.46M |
| IDYA IDEAYA Biosciences Inc. Common Stock | -4.29 2026-12-31 | -5 – -3.49 | 13 | — | — | — | 2 / 13 | $34.08M |
| IMA ImageneBio Inc. Common Stock | -4.1 2026-12-31 | -5.39 – -3.35 | 3 | — | — | — | 0 / 2 | $0 |
| IMMX Immix Biopharma Inc. Common Stock | -0.71 2026-12-31 | -0.87 – -0.57 | 8 | — | — | — | 3 / 1 | $0 |
| INAB IN8bio Inc. Common Stock | -1.24 2026-12-31 | -2.1 – -0.87 | 4 | — | — | — | 2 / 1 | $0 |
| INMB INmune Bio Inc. Common stock | -0.6 2026-12-31 | -0.82 – -0.44 | 3 | — | — | — | 2 / 0 | $0 |
| IOVA Iovance Biotherapeutics Inc. Common Stock | -0.56 2026-12-31 | -0.72 – -0.46 | 8 | — | — | — | 2 / 4 | $362.11M |
| KRRO Korro Bio Inc. Common Stock | -5.18 2026-12-31 | -7.08 – -3.2 | 9 | — | — | — | 5 / 2 | $500K |
| KYNB Kyntra Bio Inc. Common Stock | -13.75 2026-12-31 | -15.37 – -12.41 | 3 | — | — | — | 0 / 1 | $9.95M |
| LFCR Lifecore Biomedical Inc. Common Stock | -1.05 2026-12-31 | -1.22 – -0.97 | 4 | — | — | — | 0 / 3 | $122.18M |
| LONA LeonaBio Inc. Common Stock | -3.12 2026-12-31 | -4.35 – -1.87 | 3 | — | — | — | 1 / 1 | $0 |
| MBRX Moleculin Biotech Inc. Common Stock | -5.41 2026-12-31 | -6.03 – -4.6 | 3 | — | — | — | 2 / 1 | $0 |
| MBX MBX Biosciences Inc. Common Stock | -2.71 2026-12-31 | -3.22 – -2.32 | 8 | — | — | — | 7 / 2 | $0 |
| MREO Mereo BioPharma Group plc American Depositary Shares | -0.03 2026-12-31 | -0.04 – -0.02 | 5 | — | — | — | 1 / 1 | $7.09M |
| MSLE Satellos Bioscience Inc. Common Stock | -2.52 2026-12-31 | -4.46 – -1.67 | 4 | — | — | — | 1 / 1 | $0 |
| NBTX Nanobiotix S.A. American Depositary Shares | -0.13 2026-12-31 | -0.6 – 0.63 | 3 | — | — | — | 0 / 0 | $38.06M |
| OBIO Orchestra BioMed Holdings Inc. Ordinary Shares | -1.5 2026-12-31 | -1.6 – -1.3 | 5 | — | — | — | 5 / 0 | $469.67K |
| ONCY Oncolytics Biotech Inc. Common Stock | -0.34 2026-12-31 | -0.37 – -0.3 | 4 | — | — | — | 1 / 2 | $0 |
| PACB Pacific Biosciences of California Inc. Common Stock | -0.51 2026-12-31 | -0.52 – -0.49 | 5 | — | — | — | 0 / 1 | $167.43M |
| PALI Palisade Bio Inc. Common Stock | -0.24 2026-12-31 | -0.42 – -0.18 | 7 | — | — | — | 1 / 0 | $0 |
| PDSB PDS Biotechnology Corporation Common Stock | -0.5 2026-12-31 | -0.6 – -0.44 | 3 | — | — | — | 1 / 0 | $0 |
| PRCT PROCEPT BioRobotics Corporation Common Stock | -1.55 2026-12-31 | -1.72 – -1.43 | 11 | — | — | — | 2 / 1 | $397.43M |
| RCUS Arcus Biosciences Inc. Common Stock | -3.48 2026-12-31 | -4.88 – -2.63 | 7 | — | — | — | 1 / 2 | $85.06M |
| RGNX REGENXBIO Inc. Common Stock | -2.79 2026-12-31 | -4.91 – 1.61 | 8 | — | — | — | 2 / 1 | $237.89M |
| RPID Rapid Micro Biosystems Inc. Class A Common Stock | -0.93 2026-12-31 | -0.94 – -0.91 | 3 | — | — | — | 1 / 2 | $39.3M |
| SABS SAB Biotherapeutics Inc. Common Stock | -1.28 2026-12-31 | -1.88 – -1.06 | 4 | — | — | — | 0 / 0 | $0 |
| SANA Sana Biotechnology Inc. Common Stock | -0.58 2026-12-31 | -0.68 – -0.53 | 4 | — | — | — | 1 / 0 | $0 |
| SGMT Sagimet Biosciences Inc. Series A Common Stock | -1.22 2026-12-31 | -1.51 – -0.89 | 9 | — | — | — | 6 / 1 | $0 |
| SKYE Skye Bioscience Inc. Common Stock | -1.05 2026-12-31 | -1.44 – -0.63 | 5 | — | — | — | 3 / 1 | $0 |
| SLDB Solid Biosciences Inc. Common Stock | -1.96 2026-12-31 | -2.51 – -1.67 | 13 | — | — | — | 1 / 12 | $0 |
| SNTI Senti Biosciences Holdings Inc. Common Stock | -1.16 2026-12-31 | -1.38 – -0.78 | 3 | — | — | — | 0 / 0 | $33.33K |
| SPRB Spruce Biosciences Inc. Common Stock | -24.89 2026-12-31 | -33.25 – -20.39 | 7 | — | — | — | 2 / 2 | $0 |
| TELA TELA Bio Inc. Common Stock | -0.67 2026-12-31 | -0.69 – -0.62 | 5 | — | — | — | 1 / 1 | $86.71M |
| TRAX First Tracks Biotherapeutics Inc. Ordinary Shares | -3.6 2026-12-31 | -4.17 – -3.3 | 8 | — | — | — | 0 / 1 | $0 |
| TYRA Tyra Biosciences Inc. Common Stock | -2.57 2026-12-31 | -2.82 – -2.31 | 14 | — | — | — | 1 / 0 | $0 |
| UPB Upstream Bio Inc. Common Stock | -2.84 2026-12-31 | -3.37 – -2.25 | 9 | — | — | — | 5 / 3 | $2.04M |
| VIR Vir Biotechnology Inc. Common Stock | -1.37 2026-12-31 | -1.74 – -1.2 | 5 | — | — | — | 2 / 2 | $249.42M |
| XERS Xeris Biopharma Holdings Inc. Common Stock | 0.14 2026-12-31 | 0.11 – 0.19 | 4 | — | — | — | 2 / 1 | $385.94M |
| ZURA Zura Bio Limited Class A Ordinary Shares | -0.72 2026-12-31 | -0.78 – -0.64 | 3 | — | — | — | 1 / 0 | $0 |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。